Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation

49 Pages Posted: 21 Mar 2015

See all articles by Christopher M. Holman

Christopher M. Holman

University of Missouri - Kansas City School of Law

Date Written: 2011

Abstract

In recent years, the major innovator pharmaceutical companies have experienced two pronounced and significant trends: a decreasing output of innovative new drugs and cutbacks in research and development (R&D) investment. The two phenomena probably are not unrelated and raise significant concerns for a society intent upon providing affordable health care for an aging population. While the root causes of these trends are complex and diverse, we should not overlook the critical role patents play in creating the necessary incentives for the substantial investment required to develop pharmaceutically-interesting chemical compounds into actual drugs and to take them through the clinical trials necessary for Food and Drug Administration (FDA) approval. In a recent presentation, Robert Armitage, Senior Vice President and General Counsel for Eli Lilly and Co. (Lilly), identified the high level of unpredictability in today's patent law as a significant impediment to the development of new medicines. This Article discusses various forms of unpredictability in patent law and how they impact innovators, particularly in the pharmaceutical sector, and provides some ideas for addressing the problem.

Keywords: Patents, patent policy, pharmaceutical patents, drug patents, pharmaceutical innovation

Suggested Citation

Holman, Christopher M., Unpredictability in Patent Law and Its Effect on Pharmaceutical Innovation (2011). Missouri Law Review, Vol. 76, p. 645, 2011, Available at SSRN: https://ssrn.com/abstract=2581168

Christopher M. Holman (Contact Author)

University of Missouri - Kansas City School of Law ( email )

5100 Rockhill Road
Kansas City, MO 64110-2499
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
39
Abstract Views
323
PlumX Metrics